INSIGHTS ON DOWNSTREAM MANUFACTURING

• Reducing Errors With The Alliance iS HPLC System

  Explore these highlighted features of the Alliance iS HPLC System and how it reduces human errors in LC analysis.

• Meet Your New Lab Ally - The Alliance iS HPLC System

  The Alliance iS HPLC System is designed to simplify the QC lab experience and reduce the number of human errors by up to 40 percent.

• Depth Filtration Devices For Cell Cultures, Fermentation Broths, And Cell Lysates

  Typically, devices containing depth media filters can offer more efficient filtration. Browse depth filtration products and devices for the downstream processing of cell culture solutions, fermentation broths, and lysates.

• Development Of Protein A Continuous Chromatography

  This presentation focuses on the conversion of a batch ProA step using Amsphere A3 resin to a 4-column continuous process on a BioSMB system.

• Slurry Bin Functionality With The DAC Ergo

  3/22/2023

  Check out how our optional stainless-steel bin works in conjunction with the DAC Ergo to capture spent media.

• Break Free From The Protein A Low-Productivity Paradigm

  3/22/2023

  Protein A resins, with low flow rates and mass transport, lead to low productivity. Discover a solution that removes the bottleneck, offering a disposable alternative for mAb capture.

• Overcome The Hidden Complexities Of mRNA Process Development

  3/22/2023

  Behind the perceived simplicity of mRNA process development, there are many challenges. Explore these challenges as well as characterization strategies and models for predicting process outcomes at early stages.

• A Novel Downstream Processing System For Cell Line Development Workflows

  3/21/2023

  A novel downstream processing system was developed to mitigate the downstream processing bottleneck in cell line development. Evaluate the performance of this innovative system in a mAb production process.

• Performance Of A Fully Automated, Single-Use TFF System In ADC Processes

  3/21/2023

  Antibody-drug conjugates (ADCs) represent a significant area of growth in the biopharmaceutical industry. Explore the capabilities of a highly scalable, productive platform to streamline ADC production processes.